The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis

Clinical Rheumatology

Volumn 37, Issue 2, 2018, Pages 515-526

  Vlachopoulos, C ^a   Gravos, A ^a   Georgiopoulos, G ^a   Terentes Printzios, D ^a   Ioakeimidis, N ^a   Vassilopoulos, D ^a   Stamatelopoulos, K ^a   Tousoulis, D ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Arterial stiffness; Augmentation index; Pulse wave velocity; Rheumatoid arthritis; TNF a antagonists

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR;

ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; DAS28; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PULSE WAVE; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; WAVE REFLECTION; ANTAGONISTS AND INHIBITORS; DRUG EFFECT; PATHOPHYSIOLOGY;

ADALIMUMAB; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ETANERCEPT; HUMANS; INFLIXIMAB; PULSE WAVE ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR STIFFNESS;

EID: 85019014788     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-017-3657-y     Document Type: Article

References (41)

1. Wolfe F, Mitchell DM, Sibley JT et al (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37:481–494
2. Lindhardsen J, Ahlehoff O, Gislason GH et al (2011) The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis 70:929–934
3. Atzeni F, Turiel M, Caporali R et al (2010) The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases. Autoimmun Rev 9:835–839
4. Barnabe C, Martin BJ, Ghali WA (2011) Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res (Hoboken) 63:522–529
5. Arnett DK, Evans GW, Riley WA (1994) Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol 140:669–682
6. Weber T, Auer J, O’Rourke MF et al (2004) Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 109:184–189
7. Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318–1327
8. Mäki-Petäjä KM, Hall FC, Booth AD et al (2006) Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 114:1185–1192
9. Van Doornum S, McColl G, Wicks IP (2005) Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. Rheumatol Oxf Engl 44:1428–1432
10. Cypiene A, Laucevicius A, Venalis A et al (2007) Non-invasive assessment of arterial stiffness indices by applanation tonometry and pulse wave analysis in patients with rheumatoid arthritis treated with TNF-alpha blocker Remicade (infliximab). Proc West Pharmacol Soc 50:119–122
11. Komai N, Morita Y, Sakuta T, Kuwabara A, Kashihara N (2007) Antitumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis. Mod Rheumatol 17:385–390
12. Wong M, Oakley SP, Young L et al (2009) Infliximab improves vascular stiffness in patients with rheumatoid arthritis. Ann Rheum Dis 68:1277–1284
13. Galarraga B, Khan F, Kumar P, Pullar T, Belch JJ (2009) Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis. Rheumatol Oxf Engl 48:1418–1423
14. Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D (2010) Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension 55:333–338
15. Pieringer H, Stuby U, Pohanka E, Biesenbach G (2010) Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab. Clin Rheumatol 29:723–727
16. Angel K, Provan SA, Hammer HB, Mowinckel P, Kvien TK, Atar D (2011) Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies. Fundam Clin Pharmacol 25:511–517
17. Kume K, Amano K, Yamada S et al (2011) Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: an open-label randomized controlled trial. J Rheumatol 38:216971
18. Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D (2012) Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. Am J Hypertens 25:644–650
19. Maki-Petaja KM, Elkhawad M, Cheriyan J et al (2012) Anti-tumor necrosis factor-a therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation 126:247380
20. Tam LS, Shang Q, Li EK et al (2012) Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis—a randomized trial. J Rheumatol 39:2267–2275
21. Daïen CI, Fesler P, du Cailar G et al (2013) Etanercept normalises left ventricular mass in patients with rheumatoid arthritis. Ann Rheum Dis 72:8817
22. Vassilopoulos D, Gravos A, Vlachopoulos C et al (2015) Adalimumab decreases aortic stiffness independently of its effect in disease activity in patients with rheumatoid arthritis. Clin Rheumatol 34:359–364
23. Laurent S, Cockcroft J, Van Bortel L et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588–2605
24. th Edition 2011
25. Vlachopoulos C, Xaplanteris P, Aboyans V et al (2015) The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis 241:507–532
26. Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 31:1865–1871
27. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ (2000) The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 525:263–270
28. Greenberg JD, Kremer JM, Curtis JR et al (2011) Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis 70:576–582
29. Sharman JE, Marwick TH, Gilroy D et al (2013 Dec) Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: principal findings of the BP GUIDE study. Hypertension 62(6):1138–1145
30. Borlaug BA, Olson TP, Abdelmoneim SS et al (2014 Mar 20) A randomized pilot study of aortic waveform guided therapy in chronic heart failure. J Am Heart Assoc 3(2):e000745
31. Gonzalez-Juanatey C, Llorca J, Sanchez-Andrade A et al (2006 May-Jun) Short-term adalimumab therapy improves endothelial function in patients with rheumatoid arthritis refractory to infliximab. Clin Exp Rheumatol 24(3):309–312
32. Pollono EN, Lopez-Olivo MA, Lopez JA, Suarez-Almazor ME (2010 Sep) A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol 29(9):947–955
33. Vlachopoulos C, Dima I, Aznaouridis K et al (2005) Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 112:2193–2200
34. McEniery CM, Qasem A, Schmitt M, Avolio AP, Cockcroft JR, Wilkinson IB (2003) Endothelin-1 regulates arterial pulse wave velocity in vivo. J Am Coll Cardiol 42(11):1975–1981
35. Wijbrandts CA, Van Leuven SI, Boom HD et al (2009) Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumor necrosis factor therapy in rheumatoid arthritis. Ann Rheum Dis 68:1316–1321
36. Ablin JN, Boguslavski V, Aloush V et al (2006) Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci 79(25):2364–2369
37. Angel K, Provan SA, Mowinckel P, Seljeflot I, Kvien TK, Atar D (2012 Nov) The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness. Atherosclerosis 225(1):160–165
38. Sakurai M, Yamakado T, Kurachi H et al (2007) The relationship between aortic augmentation index and pulse wave velocity: an invasive study. J Hypertens 25:391–397
39. Pietri P, Vyssoulis G, Vlachopoulos C et al (2006) Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens 24:2231–2238
40. Caluwé R, Pyfferoen L, De Boeck K et al (2016 Apr) The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials. Clin Kidney J 9(2):273–279
41. Wilkinson IB, Fuchs SA, Jansen IM et al (1998) Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16:2079–2084